BCG-injected lesions presented increased transcripts levels of (among others) HLA-A, IFNG, PD1, and 4-1BB, a finding compatible with the enhanced production of IFN-γ observed on HLA-A2-restricted TILs challenged with HLA-A2+ tumor cells preexposed to BCG in vitro. This evidence concerns the gene IFNG and neoplasm.